or Try an Advanced Search...

    Technical Analysis for LVTX - Lava Therapeutics B.V.

    Grade Last Price % Change Price Change
    F 1.87 3.89% 0.07
    LVTX closed up 3.89 percent on Monday, July 1, 2024, on 24 percent of normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical LVTX trend table...
    Date Alert Name Type % Chg
    200 DMA Resistance Bearish 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    200 DMA Resistance Bearish 3.89%
    Reversal New Lows Setup Bearish Swing Setup 3.89%
    Outside Day Range Expansion 3.89%
    Wide Bands Range Expansion 3.89%
    Gapped Up Strength 3.89%
    Oversold Stochastic Weakness 3.89%
    Wide Bands Range Expansion -0.53%
    Older End-of-Day Signals for LVTX ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance about 10 hours ago
    200 DMA Resistance about 11 hours ago
    Rose Above 10 DMA about 11 hours ago
    Up 5% about 11 hours ago
    Up 3% about 11 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    LVTX Chart by TradingView
    Basic chart:

    Profile

    Lava Therapeutics B.V., a biotechnology company, develops proprietary Vγ9Vδ2 T-cell engagers. It develops immune oncology biopharmaceuticals that delivers treatment in combination with immune recruiting and activating functionality. The company was founded in 2016 and is based in Utrecht, the Netherlands.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Life Sciences Health Sciences Pharmacy Immunocore

    Is LVTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 20 LAVA Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
    Jun 10 LAVA Announces Annual Meeting of Shareholders
    May 30 LAVA Therapeutics to Participate in the Jefferies Global Healthcare Conference
    May 21 LAVA Therapeutics GAAP EPS of -$0.02 beats by $0.20, revenue of $6.99M beats by $3.49M
    May 21 LAVA Provides Business Updates and Reports First Quarter 2024 Financial Results
    May 6 LAVA Therapeutics to Participate in the Citizens JMP Life Sciences Conference
    Mar 21 LAVA Therapeutics GAAP EPS of -$0.24 beats by $0.18
    Mar 21 LAVA Therapeutics Full Year 2023 Earnings: Revenues Disappoint
    Mar 20 LAVA Provides Business Updates and Reports Fourth Quarter and Year-End Financial Results
    Mar 5 Lava gets $7M from Pfizer as trial for cancer drug advances
    See more LVTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.47
    52 Week Low 1.131
    Average Volume 77,253
    200-Day Moving Average 2.06
    50-Day Moving Average 2.52
    20-Day Moving Average 2.12
    10-Day Moving Average 1.91
    Average True Range 0.21
    RSI (14) 35.06
    ADX 37.85
    +DI 10.10
    -DI 18.84
    Chandelier Exit (Long, 3 ATRs) 1.90
    Chandelier Exit (Short, 3 ATRs) 2.43
    Upper Bollinger Bands 2.55
    Lower Bollinger Band 1.68
    Percent B (%b) 0.22
    BandWidth 41.39
    MACD Line -0.20
    MACD Signal Line -0.19
    MACD Histogram -0.0093
    Fundamentals Value
    Market Cap 49.16 Million
    Num Shares 26.3 Million
    EPS -1.92
    Price-to-Earnings (P/E) Ratio -0.97
    Price-to-Sales 5.08
    Price-to-Book 0.81
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.22
    Resistance 3 (R3) 2.24 2.15 2.16
    Resistance 2 (R2) 2.15 2.06 2.14 2.14
    Resistance 1 (R1) 2.01 2.01 2.08 1.99 2.12
    Pivot Point 1.92 1.92 1.96 1.91 1.92
    Support 1 (S1) 1.78 1.83 1.85 1.76 1.62
    Support 2 (S2) 1.69 1.78 1.68 1.60
    Support 3 (S3) 1.55 1.69 1.58
    Support 4 (S4) 1.53